Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Planus, E.
	Articles by Wang, N.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Planus, E.
	Articles by Wang, N.


Social Bookmarking

	What's this?

Ben-Ze'ev, A. G., Robinson, S., Bucher, N. L. and Farmer, S. L (1988). Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. Proc. Nat. Acad. Sci. USA 85, 1-6.[Abstract/Free Full Text]

Bissell, M. J., Hall, H. G and Parry, G (1982). How does extracellular matrix direct gene expression?. J. Theor. Biol 99, 31-68.[Medline]

Bohuslav, J., Horejsi, V., Hansmanm, C., Stockl, J., Weidle, U. H., Majdic, O., Bartke, I., Knapp, W. and Stockinger H (1995). Urokinase plasminogen activator receptor,2-integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med 181, 1381-1390.[Abstract/Free Full Text]

Cubellis, M. V., Wun, T.-C. and Blasi, F (1990). Receptor mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9, 1079-1085.[Medline]

Dano, K., Andreasen, P. A., Grondahl-Hansen, G., Kristensen, P., Nielsen, L. S. and Skriver, L (1985). Plasminogen activators, tissue degradation and cancer. Advan. Cancer Res 91, 139-266.

Gumbiner, B. M (1996). Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84, 345-357.[Medline]

Gyetko, M. R., Todd, R. F., III, Wilkinson, C. C. and Sitrin, R. G (1994). The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest 93, 1380-1387.

Gyetko, M. R., Sitrin, R. G., Fuller, J. A., Todd, R. F., III, Petty, H. and Standiford, T. J (1995). Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J. Leuk. Biol 58, 533-538.[Abstract]

Hebert, C. A. and Baker, J. B (1988). Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin. J. Cell Biol 106, 1241-1247.[Abstract/Free Full Text]

Ingber, D. E. and Folkman, J (1989). Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J. Cell Biol 109, 317-330.[Abstract/Free Full Text]

Ingber, D. E (1990). Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc. Nat. Acad. Sci. USA 87, 3579-3583.[Abstract/Free Full Text]

Ingber, D. E., Dike, L. Hansen, L., Karp, S., Liley, H., Maniotis, A., McNamee, H., Mooney, D., Plopper, G., Sims, J. and Wang, N (1994). Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int. Rev. Cytol 150, 173-224.[Medline]

Jacobson, K., Sheets, E. D. and Simson, R (1995). Revisiting the fluid mosaic model of membranes. Science 268, 1441-1442.[Free Full Text]

Lauffenburger, D. A. and Horwitz, A. F (1996). Cell migration: a physically integrated molecular process. Cell 84, 359-369.[Medline]

Lawrence, D. A., Olsen, S. T., Palaniappamn, S. and Ginsberg, D (1994). Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. J. Biol. Chem 269, 27657-27662.[Abstract/Free Full Text]

Liotta, L. A (1992). Cancer cell invasion and metastasis. Sci. Am 266, 54-59.[Medline]

Liu, G., Shuman, M. A. and Cohen, R. L (1994). Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int. J. Cancer 60, 501-506.

Mimuro, J., Muramatsu, S., Kurano, Y., Uchida, Y., Ikadai, H., Watanabe, S. and Sakata, Y (1993). Identification of the plasminogen activator inhibitor-binding heptapeptide in vitronectin. Biochemistry 32, 2314-2320.[Medline]

Mooney, D., Hansen, L., Farmer, S., Vacanti, J. and Ingber, D (1992). Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J. Cell. Physiol 151, 497-505.[Medline]

Myohanen, H. T., Stephens, R. W., Hedman, K., Tapiovaara, H., Ronne, E., Hoyer-Hansen, G., Dano, K. and Vaheri, A (1993). Distribution and lateral mobility of the urokinase receptor complex at the cell surface. J. Histochem. Cytochem 41, 1291-1301.[Abstract]

Nusrat, A. R. and Chapman, H. A (1991). An autocrine role for urokinase inphobol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest 87, 1091-1097.

Opas, M (1989). Expression of the differentiated phenotype by epithelial cells is regulated by both biochemistry and mechanics of substratum. Dev. Biol 131, 281-293.[Medline]

Pepper, M. S. and Montesano, M (1992). Proteolytic balance and capillary morphogenesis. Cell Diff. Dev 32, 319-328.

Pepper, M. S., Sappino, A.-P., Stocklin, R., Montesano, R., Orci, L. and Vassalli, J.-D (1993). Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol 122, 673-684.[Abstract/Free Full Text]

Plopper, G. and Ingber, D. E (1993). Rapid induction and isolation of focal adhesion complexes. Biochem. Biophys. Res. Commun 193, 571-578.[Medline]

Plopper, G., McNamee, H., Dike, L., Bojanowski, K. and Ingber, D. E (1995). Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell 6, 1349-1365.[Abstract]

Ploug, M., Ronne, E., Behrendt, N., Jensen, A. L., Blasi, F. and Dano, K (1991). Cellular receptor for urokinase plasminogen activator. J. Biol. Chem 266, 1926-1933.[Abstract/Free Full Text]

Pollanen, J., Saksela, O., Salonen, E.-M., Andreasen, P., Nielsen, L., Dano, K. and Vaheri, A (1987). Distinct localization of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J. Cell Biol 104, 1085-1096.[Abstract/Free Full Text]

Quax, P. H. A., Frisdal, E., Pedersen, N., Bonavaud, S., Thibert, P., Martelly, I., Verheijen, J., Blasi, F. and Barlovatz-Meimon, G (1992). Modulation of activities and RNA of the level of components of the plasminogen activation during differentiation of human myogenic satellite cells in vitro. Dev. Biol 151, 166-175.[Medline]

Reilly, T. M., Mousa, S. A., Seetharam, R. and Racanelli, A. L (1994). Recombinant plasminogen activator inhibitor type 1: a review of structural, functional, and biological aspects. Blood Coag. Fibrinol 5, 73-81.[Medline]

Schwartz, M. A. and Ingber, D. E (1994). Integrating with integrins. Mol. Biol. Cell 5, 389-393.[Abstract]

Seiffert, D. and Loskutoff, D. J (1991). Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin. J. Biol. Chem 266, 2824-2830.[Abstract/Free Full Text]

Sheetz, M (1994). Cell migration by graded attachment to substrates and contraction. Semin. Cell Biol 5, 149-155.[Medline]

Shetty, S., Kumar, A., Jonson, A., Pueblitz, S. and Idell, S (1995). Urokinase receptor in human malignant mesothelioma cells, role in tumor cell mitogenesis and proteolysis. Am. J. Physiol 268, 972-982.

Sigurdardottir, O. and Wiman, B (1994). Identification of a PAI-1 binding site in vitronectin. Biochim. Biophys. Acta 1208, 104-110.[Medline]

Stefansson, S. and Lawrence, D. A (1996). The serpin PAI-1 inhibits cell migration by blocking integrinv 3 binding to vitronectin. Nature 383, 441-443.[Medline]

Sumiyoshi, K., Baba, S., Sakagushi, S., Urano, T., Takada, Y. and Takada, A (1991). Increase in levels of plasminogen activator and type 1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb. Res 63, 59-71.[Medline]

Van Meijer, M., Gebbink, R. K., Preissner, K. T. and Pannekoek, H (1994). Determination of the vitronectin binding site on plasminogen activator inhibitor 1 (PAI-1). FEBS Lett 352, 342-346.[Medline]

Vassalli, J.-D., Sappino, A.-P. and Belin, D (1991). The plasminogen activator/plasmin system. J. Clin. Invest 88, 1067-1072.

Waltz, D. A., Sailor, L. Z. and Chapman, H. A (1993). Cytokines induce urokinase-dependent adhesion of human myeloid cells. J. Clin. Invest 91, 1541-1552.

Wang, N., Butler, J. P. and Ingber, D. E (1993). Mechanotransduction across the cell surface and through the cytoskeleton. Science 260, 1124-1127.[Abstract/Free Full Text]

Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosenberg, S. and Chapman, H. A (1994). Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem 269, 32380-32388.[Abstract/Free Full Text]

Wei, Y., Lukashev, M., Simon, D. I., Bodary S. C., Rosenberg, S., Doyle M. V. and Chapman H. A (1996). Regulation of integrin function by the urokinase receptor. Science 273, 1551-1555.[Abstract]

Williams, E. J., Furness, J., Walsh, F. S. and Doherty, P (1994). Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM and N cadherin. Neuron 3, 583-594.

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

E. Arciniegas, M. G. Frid, I. S. Douglas, and K. R. Stenmark
Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L1 - L8.
[Abstract] [Full Text] [PDF]

F. Maquerlot, S. Galiacy, M. Malo, C. Guignabert, D. A. Lawrence, M.-P. d'Ortho, and G. Barlovatz-Meimon
Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing
Am. J. Pathol., November 1, 2006; 169(5): 1624 - 1632.
[Abstract] [Full Text] [PDF]

S.-H. Kwak, S. Mitra, K. Bdeir, D. Strassheim, J. S. Park, J. Y. Kim, S. Idell, D. Cines, and E. Abraham
The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins
J. Leukoc. Biol., October 1, 2005; 78(4): 937 - 945.
[Abstract] [Full Text] [PDF]

M. Puig-de-Morales, E. Millet, B. Fabry, D. Navajas, N. Wang, J. P. Butler, and J. J. Fredberg
Cytoskeletal mechanics in adherent human airway smooth muscle cells: probe specificity and scaling of protein-protein dynamics
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C643 - C654.
[Abstract] [Full Text] [PDF]

M. L. Wahl, T. L. Moser, and S. V. Pizzo
Angiostatin and Anti-angiogenic Therapy in Human Disease
Recent Prog. Horm. Res., January 1, 2004; 59(1): 73 - 104.
[Abstract] [Full Text]

A. E. Barani, A.-C. Durieux, O. Sabido, and D. Freyssenet
Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells
J Appl Physiol, November 1, 2003; 95(5): 2089 - 2098.
[Abstract] [Full Text] [PDF]

Y. Hirashima, H. Kobayashi, M. Suzuki, Y. Tanaka, N. Kanayama, and T. Terao
Transforming Growth Factor-{beta}1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells
J. Biol. Chem., July 11, 2003; 278(29): 26793 - 26802.
[Abstract] [Full Text] [PDF]

S. Tanaka, H. Koyama, T. Ichii, A. Shioi, M. Hosoi, E. W. Raines, and Y. Nishizawa
Fibrillar Collagen Regulation of Plasminogen Activator Inhibitor-1 Is Involved in Altered Smooth Muscle Cell Migration
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1573 - 1578.
[Abstract] [Full Text] [PDF]

B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi, and G. Barlovatz-Meimon
Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations
Am. J. Pathol., January 1, 2002; 160(1): 237 - 246.
[Abstract] [Full Text] [PDF]

S. A. Wickstrom, T. Veikkola, M. Rehn, T. Pihlajaniemi, K. Alitalo, and J. Keski-Oja
Endostatin-induced Modulation of Plasminogen Activation with Concomitant Loss of Focal Adhesions and Actin Stress Fibers in Cultured Human Endothelial Cells
Cancer Res., September 1, 2001; 61(17): 6511 - 6516.
[Abstract] [Full Text] [PDF]

B. Steffensen, L. Hakkinen, and H. Larjava
Proteolytic Events of Wound-Healing -- Coordinated Interactions Among Matrix Metalloproteinases (MMPs), Integrins, and Extracellular Matrix Molecules
Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(5): 373 - 398.
[Abstract] [Full Text] [PDF]

A J Wilson and P R Gibson
Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro
Gut, July 1, 2000; 47(1): 105 - 111.
[Abstract] [Full Text] [PDF]

Y. Ikari, K. Fujikawa, K. O. Yee, and S. M. Schwartz
alpha 1-Proteinase Inhibitor, alpha 1-Antichymotrypsin, or alpha 2-Macroglobulin Is Required for Vascular Smooth Muscle Cell Spreading in Three-dimensional Fibrin Gel
J. Biol. Chem., April 21, 2000; 275(17): 12799 - 12805.
[Abstract] [Full Text] [PDF]

L. Montero and Y. Nagamine
Regulation by p38 Mitogen-activated Protein Kinase of Adenylate- and Uridylate-Rich Element-mediated Urokinase-Type Plasminogen Activator (uPA) Messenger RNA Stability and uPA-dependent in Vitro Cell Invasion
Cancer Res., October 1, 1999; 59(20): 5286 - 5293.
[Abstract] [Full Text] [PDF]

C. Robert, I. Bolon, S. Gazzeri, S. Veyrenc, C. Brambilla, and E. Brambilla
Expression of Plasminogen Activator Inhibitors 1 and 2 in Lung Cancer and Their Role in Tumor Progression
Clin. Cancer Res., August 1, 1999; 5(8): 2094 - 2102.
[Abstract] [Full Text] [PDF]

C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola
The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1
J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Planus, E.

Articles by Wang, N.

Search for Related Content

PubMed

PubMed Citation

Articles by Planus, E.

Articles by Wang, N.

Social Bookmarking

What's this?

				F. Maquerlot, S. Galiacy, M. Malo, C. Guignabert, D. A. Lawrence, M.-P. d'Ortho, and G. Barlovatz-Meimon Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing Am. J. Pathol., November 1, 2006; 169(5): 1624 - 1632. [Abstract] [Full Text] [PDF]

				S.-H. Kwak, S. Mitra, K. Bdeir, D. Strassheim, J. S. Park, J. Y. Kim, S. Idell, D. Cines, and E. Abraham The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins J. Leukoc. Biol., October 1, 2005; 78(4): 937 - 945. [Abstract] [Full Text] [PDF]

				M. Puig-de-Morales, E. Millet, B. Fabry, D. Navajas, N. Wang, J. P. Butler, and J. J. Fredberg Cytoskeletal mechanics in adherent human airway smooth muscle cells: probe specificity and scaling of protein-protein dynamics Am J Physiol Cell Physiol, September 1, 2004; 287(3): C643 - C654. [Abstract] [Full Text] [PDF]

				M. L. Wahl, T. L. Moser, and S. V. Pizzo Angiostatin and Anti-angiogenic Therapy in Human Disease Recent Prog. Horm. Res., January 1, 2004; 59(1): 73 - 104. [Abstract] [Full Text]

				A. E. Barani, A.-C. Durieux, O. Sabido, and D. Freyssenet Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells J Appl Physiol, November 1, 2003; 95(5): 2089 - 2098. [Abstract] [Full Text] [PDF]

				Y. Hirashima, H. Kobayashi, M. Suzuki, Y. Tanaka, N. Kanayama, and T. Terao Transforming Growth Factor-{beta}1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells J. Biol. Chem., July 11, 2003; 278(29): 26793 - 26802. [Abstract] [Full Text] [PDF]

				S. Tanaka, H. Koyama, T. Ichii, A. Shioi, M. Hosoi, E. W. Raines, and Y. Nishizawa Fibrillar Collagen Regulation of Plasminogen Activator Inhibitor-1 Is Involved in Altered Smooth Muscle Cell Migration Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1573 - 1578. [Abstract] [Full Text] [PDF]

				B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi, and G. Barlovatz-Meimon Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations Am. J. Pathol., January 1, 2002; 160(1): 237 - 246. [Abstract] [Full Text] [PDF]

				S. A. Wickstrom, T. Veikkola, M. Rehn, T. Pihlajaniemi, K. Alitalo, and J. Keski-Oja Endostatin-induced Modulation of Plasminogen Activation with Concomitant Loss of Focal Adhesions and Actin Stress Fibers in Cultured Human Endothelial Cells Cancer Res., September 1, 2001; 61(17): 6511 - 6516. [Abstract] [Full Text] [PDF]

				B. Steffensen, L. Hakkinen, and H. Larjava Proteolytic Events of Wound-Healing -- Coordinated Interactions Among Matrix Metalloproteinases (MMPs), Integrins, and Extracellular Matrix Molecules Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(5): 373 - 398. [Abstract] [Full Text] [PDF]

				A J Wilson and P R Gibson Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro Gut, July 1, 2000; 47(1): 105 - 111. [Abstract] [Full Text] [PDF]

				Y. Ikari, K. Fujikawa, K. O. Yee, and S. M. Schwartz alpha 1-Proteinase Inhibitor, alpha 1-Antichymotrypsin, or alpha 2-Macroglobulin Is Required for Vascular Smooth Muscle Cell Spreading in Three-dimensional Fibrin Gel J. Biol. Chem., April 21, 2000; 275(17): 12799 - 12805. [Abstract] [Full Text] [PDF]

				L. Montero and Y. Nagamine Regulation by p38 Mitogen-activated Protein Kinase of Adenylate- and Uridylate-Rich Element-mediated Urokinase-Type Plasminogen Activator (uPA) Messenger RNA Stability and uPA-dependent in Vitro Cell Invasion Cancer Res., October 1, 1999; 59(20): 5286 - 5293. [Abstract] [Full Text] [PDF]

				C. Robert, I. Bolon, S. Gazzeri, S. Veyrenc, C. Brambilla, and E. Brambilla Expression of Plasminogen Activator Inhibitors 1 and 2 in Lung Cancer and Their Role in Tumor Progression Clin. Cancer Res., August 1, 1999; 5(8): 2094 - 2102. [Abstract] [Full Text] [PDF]

				C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1 J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411. [Abstract] [Full Text] [PDF]